Skip to content

Effect of MDR1?SLCO1B3 gene polymorphism on postoperative tacrolimus requirements in renal transplant recipients

effect of gene polymorphism on postoperative tacrolimus requirements

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BOC-16009352
Enrollment
Unknown
Registered
2016-10-09
Start date
2016-09-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal transplantation patients

Interventions

Sponsors

The third Xiangya hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Relatives donor kidney transplantation patients, men or women, aged 18 years to 65 years. No diabetes, no tuberculosis, no genetic disease and cancer history, no mental illness and family history.

Exclusion criteria

Exclusion criteria: multiple organ transplantation; patients who changed immunodepressant during the study period; patients who undergoing acute allograft rejection or transplant kidney without function; patients taken other drugs that have significant effects on tacrolimus blood concentration; patients who couldnt take clinical follow-up; other person with abnormal situation.

Design outcomes

Primary

MeasureTime frame
gene type;fentanyl dose;

Contacts

Public ContactLi Chenxing
278070156@qq.com+86 15084711431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026